Mazor Robotics Ltd – (MZOR) Shares Sold by Jane Street Group LLC

Jane Street Group LLC decreased its stake in shares of Mazor Robotics Ltd – (NASDAQ:MZOR) by 85.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,350 shares of the medical instruments supplier’s stock after selling 31,429 shares during the period. Jane Street Group LLC’s holdings in Mazor Robotics were worth $255,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of MZOR. Sumitomo Mitsui Trust Holdings Inc. bought a new position in Mazor Robotics during the third quarter valued at approximately $6,371,000. Global X MANAGEMENT CO LLC raised its position in Mazor Robotics by 5,758.8% in the third quarter. Global X MANAGEMENT CO LLC now owns 115,536 shares of the medical instruments supplier’s stock worth $5,704,000 after acquiring an additional 113,564 shares during the period. Crawford Lake Capital Management LLC bought a new position in Mazor Robotics in the third quarter worth approximately $4,554,000. Dorsey Wright & Associates bought a new position in Mazor Robotics in the third quarter worth approximately $4,537,000. Finally, Wells Fargo & Company MN raised its position in Mazor Robotics by 174.8% in the second quarter. Wells Fargo & Company MN now owns 112,539 shares of the medical instruments supplier’s stock worth $3,892,000 after acquiring an additional 71,581 shares during the period. Institutional investors own 26.37% of the company’s stock.

Shares of Mazor Robotics Ltd – (MZOR) opened at $54.02 on Friday. The stock has a market cap of $1,480.00, a price-to-earnings ratio of -77.17 and a beta of 0.96. Mazor Robotics Ltd – has a 52 week low of $20.69 and a 52 week high of $65.97.

Several research analysts have weighed in on the stock. Ladenburg Thalmann Financial Services set a $67.00 price target on shares of Mazor Robotics and gave the stock a “buy” rating in a research report on Monday, October 30th. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research report on Tuesday, November 7th. Barclays reiterated a “hold” rating and issued a $34.00 price target on shares of Mazor Robotics in a research report on Wednesday, October 11th. Zacks Investment Research downgraded shares of Mazor Robotics from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 13th. Finally, BidaskClub downgraded shares of Mazor Robotics from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. Mazor Robotics presently has an average rating of “Hold” and an average price target of $43.17.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.com-unik.info/2017/12/23/mazor-robotics-ltd-mzor-shares-sold-by-jane-street-group-llc.html.

Mazor Robotics Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Institutional Ownership by Quarter for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit